Skip to main content
. Author manuscript; available in PMC: 2014 Aug 8.
Published in final edited form as: Tohoku J Exp Med. 2012;227(4):253–262. doi: 10.1620/tjem.227.253

Table 2.

Demographic and biochemical features of patients with NAFLD and normal controls

NAFLD Controls P-value
n 169 699 NA
Gender(M/F) 42 / 127 179 / 520 0.840
Age(yrs) 56.00(49.00 – 65.50) 56.00(46.00 – 64.00) 0.55
Body height(cm) 157.27 ± 8.08 156.52 ± 8.08 0.288
Body weight(kg) 65.97 ± 10.74 53.69 ± 9.22 0.000
BMI(kg/m2) 26.59 ± 3.08 21.84 ± 2.86 0.000
SBP(mmHg) 135.90 ± 21.61 125. 49 ± 20.39 0.000
DBP(mmHg) 84.00(78.00 – 92.00) 80.00(70.00 – 85.00) 0.000
Waist(cm) 90.00(84.00 – 95.00) 75.00(69.00 – 81.00) 0.000
Hip(cm) 100.00(95.00 – 103.00) 91.00(86.75 – 95.00) 0.000
WHR 0.90(0.87 – 0.94) 0.83(0.78 – 0.87) 0.000
FPG(mmol/L) 6.37 ± 2.09 5.71 ± 1.68 0.000
TG(mmol/L) 2. 45 ± 1.90 1.28 ± 0.99 0.000
HDLc(mmol/L) 1.20(1.02 – 1.49) 1.60(1.36 – 1.90) 0.000
LDLc(mmol/L) 2.74 ± 0.93 2.64 ± 0.90 0.198
TC(mmol/L) 5.69 ± 1.16 5.44 ± 1.09 0.009
ALT(mmol/L) 36.94 ± 31.83 17.88 ± 9.56 0.000
AST(mmol/L) 31.72 ± 14.87 27.34 ± 10.61 0.001
GGT(U/L) 42.54 ± 27.95 22.03 ± 13.27 0.000
ALP(U/L) 83.43 ± 28.03 75.99 ± 24.98 0.002
FINS(mlU/L) 10.66(7.80 – 14.52) 5.05(3.39 – 7.34) 0.000
HOMA-IR 2.84(2.03 – 4.03) 1.20(0.80 – 1.83) 0.000
HSCRP(mg/L) 1.00(1.00 – 2.32) 1.00(1.00 – 2.30) 0.472

ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; FINS, fasting insulin; GGT, gamma-glutamyl transpeptidase; HDLc, high-density lipoprotein cholesterol; HOMA-IR, homoeostatic metabolic assessment insulin resistance index; HSCRP, high sensitive C-reactive protein; LDLc, low-density lipoprotein cholesterol; NA, not analyzed; NAFLD, non-alcoholic fatty liver disease; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WHR, waist-to-hip ratio.

Continuous data with skewed distribution